Vicarious Surgical Company Insiders
| RBOT Stock | USD 0.27 0.01 2.54% |
Vicarious Surgical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Vicarious Surgical stock suggests that vertually all insiders are panicking at this time. Vicarious Surgical employs about 131 people. The company is managed by 16 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 8.19 employees per reported executive.
Vicarious Surgical's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
| 2024-03-20 | William John Kelly | Disposed 1290 @ 0.34 | View | ||
| 2024-02-20 | William John Kelly | Disposed 7555 @ 0.36 | View | ||
| 2023-11-06 | William John Kelly | Disposed 4984 @ 0.45 | View | ||
| 2023-10-05 | William John Kelly | Disposed 4858 @ 0.49 | View | ||
| 2023-09-20 | Sammy Khalifa | Disposed 3133 @ 0.79 | View | ||
| 2023-09-05 | William John Kelly | Disposed 11341 @ 0.97 | View | ||
| 2023-08-24 | June Morris | Disposed 2500 @ 0.95 | View | ||
| 2023-08-21 | Sammy Khalifa | Disposed 19401 @ 0.92 | View |
Monitoring Vicarious Surgical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Vicarious |
Vicarious Surgical Management Team Effectiveness
The company has return on total asset (ROA) of (0.3841) % which means that it has lost $0.3841 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6801) %, meaning that it created substantial loss on money invested by shareholders. Vicarious Surgical's management efficiency ratios could be used to measure how well Vicarious Surgical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.56 in 2024. Return On Capital Employed is likely to drop to -0.75 in 2024. At this time, Vicarious Surgical's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.1 M in 2024.Net Income Applicable To Common Shares is likely to gain to about 6.2 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 90.9 M in 2024.
Vicarious Surgical Workforce Comparison
Vicarious Surgical is currently regarded as top stock in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 171. Vicarious Surgical totals roughly 131 in number of employees claiming about 77% of equities under Health Care industry.
Vicarious Surgical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vicarious Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vicarious Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Vicarious Surgical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
David Ho over three weeks ago Acquisition by David Ho of 45998 shares of Vicarious Surgical at 13869.09 subject to Rule 16b-3 | ||
Kelly William John over a month ago Disposition of 1290 shares by Kelly William John of Vicarious Surgical at 0.3 subject to Rule 16b-3 | ||
Kelly William John over a month ago Disposition of 4954 shares by Kelly William John of Vicarious Surgical at 2.68 subject to Rule 16b-3 | ||
Adam Sachs over two months ago Sale by Adam Sachs of 28282 shares of Vicarious Surgical | ||
Adam Sachs over three months ago Conversion by Adam Sachs of 11329 shares of Vicarious Surgical | ||
Morris June over six months ago Sale by Morris June of 1095 shares of Vicarious Surgical | ||
Morris June over six months ago Sale by Morris June of 6385 shares of Vicarious Surgical | ||
Morris June over six months ago Sale by Morris June of 6407 shares of Vicarious Surgical |
Vicarious Surgical Notable Stakeholders
A Vicarious Surgical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vicarious Surgical often face trade-offs trying to please all of them. Vicarious Surgical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vicarious Surgical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Chu | Chief Executive Officer, Director | Profile | |
| Randolph Clark | President | Profile | |
| William CPA | CFO Treasurer | Profile | |
| Robert Kirby | Chief Financial Officer | Profile | |
| CPA CPA | CFO Treasurer | Profile | |
| June Esq | Gen Officer | Profile | |
| Terry Lundgren | Independent Director | Profile | |
| Sammy Khalifa | CTO Cofounder | Profile | |
| John Mazzola | VP Operations | Profile | |
| Michael Kives | Independent Director | Profile | |
| David Ho | Independent Director | Profile | |
| Donald Tang | President Director | Profile | |
| Emma Plouffe | Vice People | Profile | |
| Fred Langhammer | Independent Director | Profile | |
| MD FACS | Cofounder Officer | Profile | |
| Adam Sachs | CEO, CoFounder | Profile |
About Vicarious Surgical Management Performance
The success or failure of an entity such as Vicarious Surgical often depends on how effective the management is. Vicarious Surgical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vicarious management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vicarious management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.59) | (0.56) | |
| Return On Capital Employed | (0.72) | (0.75) | |
| Return On Assets | (0.59) | (0.56) | |
| Return On Equity | (0.73) | (0.69) |
The data published in Vicarious Surgical's official financial statements usually reflect Vicarious Surgical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Vicarious Surgical. For example, before you start analyzing numbers published by Vicarious accountants, it's critical to develop an understanding of what Vicarious Surgical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Vicarious Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vicarious Surgical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Vicarious Surgical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vicarious Surgical. Please utilize our Beneish M Score to check the likelihood of Vicarious Surgical's management manipulating its earnings.
Vicarious Surgical Workforce Analysis
Traditionally, organizations such as Vicarious Surgical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vicarious Surgical within its industry.Vicarious Surgical Manpower Efficiency
Return on Vicarious Surgical Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 542.5K | |
| Net Loss Per Executive | 4.4M | |
| Working Capital Per Employee | 715.1K | |
| Working Capital Per Executive | 5.9M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vicarious Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Vicarious Stock please use our How to Invest in Vicarious Surgical guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Vicarious Stock analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Vicarious Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vicarious Surgical. If investors know Vicarious will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vicarious Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.49) | Return On Assets (0.38) | Return On Equity (0.68) |
The market value of Vicarious Surgical is measured differently than its book value, which is the value of Vicarious that is recorded on the company's balance sheet. Investors also form their own opinion of Vicarious Surgical's value that differs from its market value or its book value, called intrinsic value, which is Vicarious Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vicarious Surgical's market value can be influenced by many factors that don't directly affect Vicarious Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vicarious Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vicarious Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vicarious Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.